Seres Plans Deep Dive After Microbiome Drug Fails In Ulcerative Colitis Trial

 
• By Alaric DeArment
  
Bacterias 3D rendering
Seres will do a deep dive into data from its failed Phase IIb study of SER-287 in ulcerative colitis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D